China Rasagiline Tablet Market Report & Forecast 2021-2027

China Rasagiline Tablet Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Rasagiline Tablet Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Rasagiline Tablet Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Rasagiline Tablet Overall Market Size
2.1 China Rasagiline Tablet Market Size: 2021 VS 2027
2.2 China Rasagiline Tablet Revenue, Prospects & Forecasts: 2016-2027
2.3 China Rasagiline Tablet Sales: 2016-2027
3 Company Landscape
3.1 Top Rasagiline Tablet Players in China Market
3.2 Top China Rasagiline Tablet Companies Ranked by Revenue
3.3 China Rasagiline Tablet Revenue by Companies
3.4 China Rasagiline Tablet Sales by Companies
3.5 China Rasagiline Tablet Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Rasagiline Tablet Companies in China Market, by Revenue in 2020
3.7 Manufacturers Rasagiline Tablet Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rasagiline Tablet Players in China Market
3.8.1 List of Tier 1 Rasagiline Tablet Companies in China
3.8.2 List of Tier 2 and Tier 3 Rasagiline Tablet Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Rasagiline Tablet Market Size Markets, 2021 & 2027
4.1.2 0.5 mg/Pcs
4.1.3 1 mg/Pcs
4.2 By Type - China Rasagiline Tablet Revenue & Forecasts
4.2.1 By Type - China Rasagiline Tablet Revenue, 2016-2021
4.2.2 By Type - China Rasagiline Tablet Revenue, 2022-2027
4.2.3 By Type - China Rasagiline Tablet Revenue Market Share, 2016-2027
4.3 By Type - China Rasagiline Tablet Sales & Forecasts
4.3.1 By Type - China Rasagiline Tablet Sales, 2016-2021
4.3.2 By Type - China Rasagiline Tablet Sales, 2022-2027
4.3.3 By Type - China Rasagiline Tablet Sales Market Share, 2016-2027
4.4 By Type - China Rasagiline Tablet Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Rasagiline Tablet Market Size, 2021 & 2027
5.1.2 Under 40 Years Old
5.1.3 40-65 Years Old
5.1.4 Above 65 Years Old
5.2 By Application - China Rasagiline Tablet Revenue & Forecasts
5.2.1 By Application - China Rasagiline Tablet Revenue, 2016-2021
5.2.2 By Application - China Rasagiline Tablet Revenue, 2022-2027
5.2.3 By Application - China Rasagiline Tablet Revenue Market Share, 2016-2027
5.3 By Application - China Rasagiline Tablet Sales & Forecasts
5.3.1 By Application - China Rasagiline Tablet Sales, 2016-2021
5.3.2 By Application - China Rasagiline Tablet Sales, 2022-2027
5.3.3 By Application - China Rasagiline Tablet Sales Market Share, 2016-2027
5.4 By Application - China Rasagiline Tablet Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Teva Pharmaceutical
6.1.1 Teva Pharmaceutical Corporation Information
6.1.2 Teva Pharmaceutical Overview
6.1.3 Teva Pharmaceutical Rasagiline Tablet Sales and Revenue in China Market (2016-2021)
6.1.4 Teva Pharmaceutical Rasagiline Tablet Product Description
6.1.5 Teva Pharmaceutical Recent Developments
6.2 Lundbeck
6.2.1 Lundbeck Corporation Information
6.2.2 Lundbeck Overview
6.2.3 Lundbeck Rasagiline Tablet Sales and Revenue in China Market (2016-2021)
6.2.4 Lundbeck Rasagiline Tablet Product Description
6.2.5 Lundbeck Recent Developments
6.3 Sun Pharmaceutical
6.3.1 Sun Pharmaceutical Corporation Information
6.3.2 Sun Pharmaceutical Overview
6.3.3 Sun Pharmaceutical Rasagiline Tablet Sales and Revenue in China Market (2016-2021)
6.3.4 Sun Pharmaceutical Rasagiline Tablet Product Description
6.3.5 Sun Pharmaceutical Recent Developments
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Overview
6.4.3 Apotex Rasagiline Tablet Sales and Revenue in China Market (2016-2021)
6.4.4 Apotex Rasagiline Tablet Product Description
6.4.5 Apotex Recent Developments
6.5 Taj Pharma
6.5.1 Taj Pharma Corporation Information
6.5.2 Taj Pharma Overview
6.5.3 Taj Pharma Rasagiline Tablet Sales and Revenue in China Market (2016-2021)
6.5.4 Taj Pharma Rasagiline Tablet Product Description
6.5.5 Taj Pharma Recent Developments
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Overview
6.6.3 Mylan Rasagiline Tablet Sales and Revenue in China Market (2016-2021)
6.6.4 Mylan Rasagiline Tablet Product Description
6.6.5 Mylan Recent Developments
6.7 Takeda Pharmaceutical
6.7.1 Takeda Pharmaceutical Corporation Information
6.7.2 Takeda Pharmaceutical Overview
6.7.3 Takeda Pharmaceutical Rasagiline Tablet Sales and Revenue in China Market (2016-2021)
6.7.4 Takeda Pharmaceutical Rasagiline Tablet Product Description
6.7.5 Takeda Pharmaceutical Recent Developments
6.8 Sandoz
6.8.1 Sandoz Corporation Information
6.8.2 Sandoz Overview
6.8.3 Sandoz Rasagiline Tablet Sales and Revenue in China Market (2016-2021)
6.8.4 Sandoz Rasagiline Tablet Product Description
6.8.5 Sandoz Recent Developments
6.9 Intas Pharmaceuticals
6.9.1 Intas Pharmaceuticals Corporation Information
6.9.2 Intas Pharmaceuticals Overview
6.9.3 Intas Pharmaceuticals Rasagiline Tablet Sales and Revenue in China Market (2016-2021)
6.9.4 Intas Pharmaceuticals Rasagiline Tablet Product Description
6.9.5 Intas Pharmaceuticals Recent Developments
6.10 Natco Pharma
6.10.1 Natco Pharma Corporation Information
6.10.2 Natco Pharma Overview
6.10.3 Natco Pharma Rasagiline Tablet Sales and Revenue in China Market (2016-2021)
6.10.4 Natco Pharma Rasagiline Tablet Product Description
6.10.5 Natco Pharma Recent Developments
6.11 Ajanta Pharma
6.11.1 Ajanta Pharma Corporation Information
6.11.2 Ajanta Pharma Overview
6.11.3 Ajanta Pharma Rasagiline Tablet Sales and Revenue in China Market (2016-2021)
6.11.4 Ajanta Pharma Rasagiline Tablet Product Description
6.11.5 Ajanta Pharma Recent Developments
6.12 Orchid Pharma
6.12.1 Orchid Pharma Corporation Information
6.12.2 Orchid Pharma Overview
6.12.3 Orchid Pharma Rasagiline Tablet Sales and Revenue in China Market (2016-2021)
6.12.4 Orchid Pharma Rasagiline Tablet Product Description
6.12.5 Orchid Pharma Recent Developments
6.13 Alkem Laboratories
6.13.1 Alkem Laboratories Corporation Information
6.13.2 Alkem Laboratories Overview
6.13.3 Alkem Laboratories Rasagiline Tablet Sales and Revenue in China Market (2016-2021)
6.13.4 Alkem Laboratories Rasagiline Tablet Product Description
6.13.5 Alkem Laboratories Recent Developments
7 China Rasagiline Tablet Production Capacity, Analysis
7.1 China Rasagiline Tablet Production Capacity, 2016-2027
7.2 Rasagiline Tablet Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Rasagiline Tablet Supply Chain Analysis
9.1 Rasagiline Tablet Industry Value Chain
9.2 Rasagiline Tablet Upstream Market
9.3 Rasagiline Tablet Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Rasagiline Tablet Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Rasagiline Tablet in China Market
Table 2. Top Rasagiline Tablet Players in China Market, Ranking by Revenue (2019)
Table 3. China Rasagiline Tablet Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Rasagiline Tablet Revenue Share by Companies, 2016-2021
Table 5. China Rasagiline Tablet Sales by Companies, (M Pcs), 2016-2021
Table 6. China Rasagiline Tablet Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Rasagiline Tablet Price (2016-2021) & (USD/K Pcs)
Table 8. Manufacturers Rasagiline Tablet Product Type
Table 9. List of Tier 1 Rasagiline Tablet Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Rasagiline Tablet Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of 0.5 mg/Pcs
Table 12. Major Manufacturers of 1 mg/Pcs
Table 13. By Type - China Rasagiline Tablet Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Rasagiline Tablet Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Rasagiline Tablet Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Rasagiline Tablet Sales (M Pcs), 2016-2021
Table 17. By Type - China Rasagiline Tablet Sales (M Pcs), 2022-2027
Table 18. By Application - China Rasagiline Tablet Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Rasagiline Tablet Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Rasagiline Tablet Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Rasagiline Tablet Sales (M Pcs), 2016-2021
Table 22. By Application - China Rasagiline Tablet Sales (M Pcs), 2022-2027
Table 23. Teva Pharmaceutical Corporation Information
Table 24. Teva Pharmaceutical Description and Major Businesses
Table 25. Teva Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/K Pcs) (2016-2021)
Table 26. Teva Pharmaceutical Rasagiline Tablet Product
Table 27. Teva Pharmaceutical Recent Developments
Table 28. Lundbeck Corporation Information
Table 29. Lundbeck Description and Major Businesses
Table 30. Lundbeck Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/K Pcs) (2016-2021)
Table 31. Lundbeck Rasagiline Tablet Product
Table 32. Lundbeck Recent Developments
Table 33. Sun Pharmaceutical Corporation Information
Table 34. Sun Pharmaceutical Description and Major Businesses
Table 35. Sun Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/K Pcs) (2016-2021)
Table 36. Sun Pharmaceutical Rasagiline Tablet Product
Table 37. Sun Pharmaceutical Recent Developments
Table 38. Apotex Corporation Information
Table 39. Apotex Description and Major Businesses
Table 40. Apotex Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/K Pcs) (2016-2021)
Table 41. Apotex Rasagiline Tablet Product
Table 42. Apotex Recent Developments
Table 43. Taj Pharma Corporation Information
Table 44. Taj Pharma Description and Major Businesses
Table 45. Taj Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/K Pcs) (2016-2021)
Table 46. Taj Pharma Rasagiline Tablet Product
Table 47. Taj Pharma Recent Developments
Table 48. Mylan Corporation Information
Table 49. Mylan Description and Major Businesses
Table 50. Mylan Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/K Pcs) (2016-2021)
Table 51. Mylan Rasagiline Tablet Product
Table 52. Mylan Recent Developments
Table 53. Takeda Pharmaceutical Corporation Information
Table 54. Takeda Pharmaceutical Description and Major Businesses
Table 55. Takeda Pharmaceutical Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/K Pcs) (2016-2021)
Table 56. Takeda Pharmaceutical Rasagiline Tablet Product
Table 57. Takeda Pharmaceutical Recent Developments
Table 58. Sandoz Corporation Information
Table 59. Sandoz Description and Major Businesses
Table 60. Sandoz Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/K Pcs) (2016-2021)
Table 61. Sandoz Rasagiline Tablet Product
Table 62. Sandoz Recent Developments
Table 63. Intas Pharmaceuticals Corporation Information
Table 64. Intas Pharmaceuticals Description and Major Businesses
Table 65. Intas Pharmaceuticals Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/K Pcs) (2016-2021)
Table 66. Intas Pharmaceuticals Rasagiline Tablet Product
Table 67. Intas Pharmaceuticals Recent Developments
Table 68. Natco Pharma Corporation Information
Table 69. Natco Pharma Description and Major Businesses
Table 70. Natco Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/K Pcs) (2016-2021)
Table 71. Natco Pharma Rasagiline Tablet Product
Table 72. Natco Pharma Recent Developments
Table 73. Ajanta Pharma Corporation Information
Table 74. Ajanta Pharma Description and Major Businesses
Table 75. Ajanta Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/K Pcs) (2016-2021)
Table 76. Ajanta Pharma Rasagiline Tablet Product
Table 77. Ajanta Pharma Recent Developments
Table 78. Orchid Pharma Corporation Information
Table 79. Orchid Pharma Description and Major Businesses
Table 80. Orchid Pharma Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/K Pcs) (2016-2021)
Table 81. Orchid Pharma Rasagiline Tablet Product
Table 82. Orchid Pharma Recent Developments
Table 83. Alkem Laboratories Corporation Information
Table 84. Alkem Laboratories Description and Major Businesses
Table 85. Alkem Laboratories Rasagiline Tablet Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/K Pcs) (2016-2021)
Table 86. Alkem Laboratories Rasagiline Tablet Product
Table 87. Alkem Laboratories Recent Developments
Table 88. Rasagiline Tablet Production Capacity (M Pcs) of Key Manufacturers in China Market, 2019-2021 (M Pcs)
Table 89. China Rasagiline Tablet Capacity Market Share of Key Manufacturers, 2019-2021
Table 90. Rasagiline Tablet Market Opportunities & Trends in China Market
Table 91. Rasagiline Tablet Market Drivers in China Market
Table 92. Rasagiline Tablet Market Restraints in China Market
Table 93. Rasagiline Tablet Raw Materials
Table 94. Rasagiline Tablet Raw Materials Suppliers in China Market
Table 95. Typical Rasagiline Tablet Downstream
Table 96. Rasagiline Tablet Downstream Clients in China Market
Table 97. Rasagiline Tablet Distributors and Sales Agents in China Market
List of Figures
Figure 1. Rasagiline Tablet Product Picture
Figure 2. Rasagiline Tablet Segment by Type
Figure 3. Rasagiline Tablet Segment by Application
Figure 4. China Rasagiline Tablet Market Overview: 2020
Figure 5. China Rasagiline Tablet Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Rasagiline Tablet Revenue, 2016-2027 (US$, Mn)
Figure 7. Rasagiline Tablet Sales in China Market: 2016-2027 (M Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Rasagiline Tablet Revenue in 2020
Figure 9. 0.5 mg/Pcs Product Picture
Figure 10. 1 mg/Pcs Product Picture
Figure 11. By Type - China Rasagiline Tablet Sales Market Share, 2016-2027
Figure 12. By Type - China Rasagiline Tablet Revenue Market Share, 2016-2027
Figure 13. By Type - China Rasagiline Tablet Price (USD/K Pcs), 2016-2027
Figure 14. Under 40 Years Old
Figure 15. 40-65 Years Old
Figure 16. Above 65 Years Old
Figure 17. By Application - China Rasagiline Tablet Sales Market Share, 2016-2027
Figure 18. By Application - China Rasagiline Tablet Revenue Market Share, 2016-2027
Figure 19. By Application - China Rasagiline Tablet Price (USD/K Pcs), 2016-2027
Figure 20. Teva Pharmaceutical Rasagiline Tablet Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Lundbeck Rasagiline Tablet Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Sun Pharmaceutical Rasagiline Tablet Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Apotex Rasagiline Tablet Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Taj Pharma Rasagiline Tablet Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Mylan Rasagiline Tablet Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Takeda Pharmaceutical Rasagiline Tablet Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Sandoz Rasagiline Tablet Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Intas Pharmaceuticals Rasagiline Tablet Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Natco Pharma Rasagiline Tablet Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Ajanta Pharma Rasagiline Tablet Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Orchid Pharma Rasagiline Tablet Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Alkem Laboratories Rasagiline Tablet Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. China Rasagiline Tablet Production Capacity (M Pcs), 2016-2027
Figure 34. Rasagiline Tablet Industry Value Chain
Figure 35. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs